Statistical Analysis of Prevalence, Incidence, Comorbidities and Medical Expense in Epileptic Children in Taiwan Based on National Health Research Insurance Database.

Statistical Analysis of Prevalence, Incidence, Comorbidities and Medical Expense in Epileptic Children in Taiwan Based on National Health Research Insurance Database

Epilepsy is a common disease in pediatric neurology. In recent years, due to the promotion of Taiwan's health insurance and the advancement of related medical treatments and anti-epileptic drugs, the prevalence, incidence, and related comorbidities of childhood epilepsy in Taiwan are expected, as well as the number of epilepsy patients in different regions or different age groups. and medical costs may change. This study aims to collect data from the National Health Insurance Database through the National Institutes of Health, review relevant data on childhood epilepsy patients from 2001 to 2013, and analyze trends to discuss the impact of universal health insurance and medical progress on childhood epilepsy patients. Impact.

Study Overview

• Status: Completed
• Conditions: Neurologic Disorder; Seizure Disorder
• Intervention / Treatment: Other: seizure

• Study Type: Observational
• Enrollment (Actual): 169026

Contacts and Locations

Study Locations

• Taiwan
  • Tainan, Taiwan, 100
    • National Taiwan University Hospital
  • Taipei, Taiwan
    • Department of Pediatrics, National Taiwan University Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Probability Sample

Study Population

Patients suffering from epilepsy

Description

Inclusion Criteria:

1. Targets aged 0~19 (<=19) in the home country
2. Diagnosis code includes ICD9: 345.XX, ACODE:A225 (including outpatient and inpatient)
3. Between 2001 and 2013, those who had seen a doctor three times in a row with epilepsy diagnosis codes and used anti-epileptic drugs

Exclusion Criteria:

• Exclude those who sought medical treatment for epilepsy from 2001 to 2013, but the number of medical visits (outpatient + hospitalization) <3 times, and exclude those who did not take medication from 2001 to 2013.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Statistical Analysis of prevalence, incidence, comorbidities and medical expense medical expense in epileptic children in Taiwan based	in epileptic children in Taiwan based	2001-2013

Collaborators and Investigators

• Sponsor: National Taiwan University Hospital
• Investigators: Study Director: Mei Lan Liou, master, National Taiwan University Hospital

Study record dates

Study Major Dates

• Study Start (Actual): March 9, 2018
• Primary Completion (Actual): January 4, 2019
• Study Completion (Actual): February 19, 2021

Study Registration Dates

• First Submitted: August 5, 2024
• First Submitted That Met QC Criteria: August 5, 2024
• First Posted (Actual): August 7, 2024

Study Record Updates

• Last Update Posted (Actual): August 7, 2024
• Last Update Submitted That Met QC Criteria: August 5, 2024
• Last Verified: August 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Brain Diseases; Central Nervous System Diseases; Neurologic Manifestations; Epilepsy; Nervous System Diseases; Seizures
• Other Study ID Numbers: 201802028RINB

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No